A condensed ring compound capable of becoming an intermediate product suitable for isoxazolines is represented by formula (I). In formula (I), X" represents a halogen atom or the like； n represents any one of integers 0 to 5； X' represents a halogen atom or the like； m represents any one of integers 0 to 7； R1 represents a haloalkyl group or the like； R2 represents a hydrogen atom, a halogen atom, a C1-6 alkoxy group or the like； R3 represents a hydrogen atom, a halogen atom, a C1-6 alkoxy group or the like； q represents 1 or 2； p represents 0 or 1； and the binding between C1 and C2 represents a single bond when p is 1 and a double bond when p is 0.
